Angiogenesis is a major hallmark of malignancy4, 5 and can be evaluated by tumour microvessel density (MVD), as demonstrated widely by immunocytochemical staining for CD31 and CD34 in tumours6, including lung cancer7, 8. Here, PECAM1 is linked to neoplasm.